Paraffin

Summary

Paraffin (CHEMBL2108076) is a phase-3 clinical-stage unknown; indicated across 2 conditions including atopic eczema.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Unknown
• Indications: 2 conditions
• Clinical trials: 15

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108076
Name	Paraffin
Type	Unknown
Max phase	3

Also known as: FEMA NO. 3216, Hard paraffin, Paraffin, Paraffin wax, white soft, Paraffinum, Paraffinum durum, Petroleum wax, crystalline, PARAFFINE, PARAFFIN

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
atopic eczema	3	MONDO:0004980	EFO:0000274

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 15.

Phase distribution

Phase	Trials
Not specified	13
PHASE2/PHASE3	1
PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01391624	PHASE2/PHASE3	COMPLETED	Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers
NCT03641053	PHASE3	COMPLETED	Honey Versus Povidone-iodine on Laceration Wounds
NCT06702514	Not specified	NOT_YET_RECRUITING	Balneotherapy in Hand Osteoarthritis
NCT06786884	Not specified	RECRUITING	Paraffin Wax and Exercise Prospective
NCT06986668	Not specified	ENROLLING_BY_INVITATION	Efficacy of Paraffin Bath and Peloidotherapy in Carpal Tunnel Syndrome
NCT07167667	Not specified	RECRUITING	Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities
NCT07256522	Not specified	RECRUITING	Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
NCT02185950	Not specified	UNKNOWN	The Effects of Therapeutic Resources on Structure and Function of Normal and Burned Skin
NCT02278289	Not specified	COMPLETED	Comparative Effectiveness of Ultrasound and Paraffin Therapy in Patients With Carpal Tunnel Syndrome: A Randomized Trial
NCT02986672	Not specified	COMPLETED	Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)
NCT03026270	Not specified	UNKNOWN	Effect of Therapeutical Paraffin in the Malleability of Burned Skin
NCT03061422	Not specified	UNKNOWN	Effect of Xylitol-Containing Chewing Gum With/Without Bicarbonate Versus Paraffin Pellet on Salivary pH
NCT03839108	Not specified	COMPLETED	Comparison of Effect of Prolotherapy and Paraffin Waxes for Hand Osteoarthritis
NCT05641038	Not specified	COMPLETED	Comparison Of The Efficiencies Of Peloid and Paraffine Treatments In Patients With Hallux Rigidus
NCT06370091	Not specified	COMPLETED	Effect of Xylitol-based Chewing Gums, Sugar-free and Sugared, on Salivary Flow and pH in Young Adults

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).